HIGHLIGHTS
- who: . and colleagues from the Economics, Italy University of Kansas Medical Center have published the research work: CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the pharmaceutical effects of CGX against colon-liver metastasis using a murine colon carcinoma (MC)38-splenic injection mouse model under both normal and fat diet conditions. In the present study, Western blot data were presented with one of them as representative image.
- how: The animal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.